Preclinical Evaluation

How AI Accelerates Drug Discovery: The Pipeline Stages, the Methods, and the Limits

Artificial intelligence is accelerating drug discovery by applying machine learning techniques across pipeline stages, from target identification to preclinical evaluation, enhancing efficiency and reducing costs. The article also details the methods used and the critical challenges of data quality and interpretability that still constrain AI's impact.